Cell surface molecules that are differentially expressed on particular subpopulations of cells may act to regulate cell growth and differentiation or mediate cell interactions with the external environment. Transformed cells may show abnormal expression of particular cell surface molecules, and, in some cases, this abnormal expression may mediate the transformed state. The objective of this project is to define genes that control the cell surface expression of the Thy-1 and Lyt-2 glycoproteins and to determine their mechanism of action. Specific somatic cell mutants provide a way to study the control of the expression of cell surface molecules, particularly when coupled with the use of molecular genetic techniques to introduce specific genes into mutant cell lines. A Thy-1- mutant that acts in trans position to extinguish expression of Thy-1 in hybrids of the mutant with wild-type Thy-1+ cell lines has been described. Nuclear runoff transcription assays will be used to determine whether the gene product defined by this mutant acts transcriptionally. Proteins that bind to the DNA of this Thy-1- mutant and its Thy-1+ revertant will be characterized. Transfection and somatic cell fusion will be used to define regions of the Thy-1 gene that interact with the gene product defined by this mutant. Retroviral insertional mutagenesis will be used to attempt to identify and isolate the gene defined by the mutant. Somatic cell mutants will also be used to define regions important in controlling the expression of the Lyt-2 gene. Southern blotting analysis of one mutant will be used to define a sequence that acts in cis position to activate Lyt-2 expression The gene(s) that act to regulate Lyt-2 and Thy-1 expression in interlineage hybrids will be characterized using a combination of segregation analysis and the introduction of genes into hybrids by transfection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA013287-23
Application #
2086116
Study Section
Special Emphasis Panel (NSS)
Project Start
1978-06-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
23
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Lesley, J; Kincade, P W; Hyman, R (1993) Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol 23:1902-9
Lesley, J; Hyman, R; Kincade, P W (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335
Kincade, P W; He, Q; Ishihara, K et al. (1993) CD44 and other cell interaction molecules contributing to B lymphopoiesis. Curr Top Microbiol Immunol 184:215-22
Takahashi, M; Takeda, J; Hirose, S et al. (1993) Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 177:517-21
Anson, D S; Clarkin, K; Hyman, R (1992) Activation of Lyt-2 associated with distant upstream insertion of an SL3-3 provirus. Immunogenetics 36:3-14
He, Q; Lesley, J; Hyman, R et al. (1992) Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 119:1711-9
Hyman, R; Stallings, V (1992) Coordinate change in phenotype in a mouse cell line selected for CD8 expression. Immunogenetics 36:149-56
Lesley, J; He, Q; Miyake, K et al. (1992) Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med 175:257-66
Lesley, J; Hyman, R (1992) CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719-23
Baughman, G; Lesley, J; Trotter, J et al. (1992) Tcl-30, a new T cell-specific gene expressed in immature glucocorticoid-sensitive thymocytes. J Immunol 149:1488-96

Showing the most recent 10 out of 24 publications